Cardioembolic stroke is the most serious problem in the aging society: Japan standard stroke registry study

Yuji Kato1, Takeshi Hayashi1, Norio Tanahashi1

  • 1Department of Neurology and Cerebrovascular Medicine, Saitama International Medical Center, Saitama Medical University, Saitama, Japan.

Insights

In Japan's aging population, cardioembolic stroke is most common in older adults. Risk factors like hypertension and diabetes are key in younger stroke patients, while atrial fibrillation dominates in the elderly.

Area of Science:

  • Geriatric Medicine
  • Neurology
  • Epidemiology

Background:

  • Japan faces a rapidly aging population, presenting unique challenges in healthcare.
  • Older individuals exhibit distinct stroke risk profiles and clinical presentations compared to younger demographics.

Purpose of the Study:

  • To investigate stroke subtypes, risk factor prevalence, severity, and functional outcomes across different age groups in Japan.
  • To understand the evolving landscape of stroke in an aging society.

Main Methods:

  • A large-scale, multicenter hospital-based registration study.
  • Inclusion of 78,096 patients with acute ischemic stroke (including transient ischemic attacks) from 95 Japanese institutes (2000-2012).

Main Results:

  • Cardioembolic stroke and atrial fibrillation prevalence increased significantly in individuals over 90 years old.
  • Increasing age correlated with more severe stroke symptoms and poorer functional outcomes.
  • Hypertension peaked in the 70s, while diabetes and hyperlipidemia were most frequent in the 50s-60s.

Conclusions:

  • Cardioembolic stroke is the predominant subtype in Japan's aging population.
  • Hypertension, diabetes, and hyperlipidemia are significant risk factors in middle-aged stroke patients (50s-60s).
  • Atrial fibrillation becomes a more critical factor for stroke in advanced age.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
345
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
375
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
356
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
357
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
597